Trust Size
$13M
What Happened
Apexigen, Inc. filed its S-1 registration in 2021 and completed its business combination in 2023. The company was delisted from exchanges with 202 SEC filings on record.
Apexigen, Inc. entered the SPAC market in 2021 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
The company filed a definitive proxy statement (DEFM14A) ahead of its merger vote, completing its de-SPAC transaction in 2023.
SEC records show 202 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company's last SEC filing was 2023-09-05, and it appears to have been delisted from exchanges â a common fate for SPACs that fail to meet listing requirements or generate sufficient shareholder interest.
The company was incorporated in Delaware, the preferred jurisdiction for the vast majority of SPACs due to its business-friendly legal framework.
Timeline
2021-01-07
S-1 Registration Filed
2023-06-30
Merger Proxy Filed (DEFM14A)
2023-09-05
Last SEC Filing
SEC Filing Details
CIK Number
1814140
Total SEC Filings
202
State of Incorporation
DE
Last Filing Date
2023-09-05
Business Location
New York, NY
Trust/Asset Size
$13M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
ð SEC Filings
View all EDGAR filings for Apexigen